Showing results (1-10 of 255) with videos related to

Sort By:
Pageof 26
Neuropharmacology|June 6, 2022
(2R,6R)-hydroxynorketamine rapidly potentiates optically-evoked Schaffer collateral synaptic activityLace M Riggs, Scott M Thompson, Todd D Gould
Journal of Neurophysiology|December 5, 2023
cAMP-dependent protein kinase signaling is required for (<i>2R,6R</i>)-hydroxynorketamine to potentiate hippocampal glutamatergic transmissionLace M Riggs, Edna F R Pereira, Scott M Thompson, et al.
Annual Review of Clinical Psychology|February 9, 2021
Ketamine and the Future of Rapid-Acting AntidepressantsLace M Riggs, Todd D Gould
Biochemical Pharmacology|December 30, 2021
Mechanisms of ketamine and its metabolites as antidepressantsEvan M Hess, Lace M Riggs, Michael Michaelides, et al.
Translational Psychiatry|November 13, 2021
(R,S)-ketamine and (2R,6R)-hydroxynorketamine differentially affect memory as a function of dosing frequencyLace M Riggs, Xiaoxian An, Edna F R Pereira, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 20, 2019
(2R,6R)-hydroxynorketamine rapidly potentiates hippocampal glutamatergic transmission through a synapse-specific presynaptic mechanismLace M Riggs, Yasco Aracava, Panos Zanos, et al.
Annual Review of Pharmacology and Toxicology|October 10, 2018
Molecular Pharmacology and Neurobiology of Rapid-Acting AntidepressantsTodd D Gould, Carlos A Zarate, Scott M Thompson
CNS Drugs|March 9, 2018
Convergent Mechanisms Underlying Rapid Antidepressant ActionPanos Zanos, Scott M Thompson, Ronald S Duman, et al.
Pageof 26